# clm_2A39068943F3

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: quarterly_operating_income  
value: 1,693,000,000 United States dollar  
valid_from: 2026-06-30  
valid_to: 2026-09-30  
published: 2026-07-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_2416CD508AED  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories quarterly operating income: 1,693,000,000 United States dollar", as of 2026-06-30 (until 2026-09-30). Claim clm_2A39068943F3, https://asof.is/claim/clm_2A39068943F3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/0001628280-26-050134-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2026, filed 2026-07-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/0001628280-26-050134-index.htm (primary, SEC EDGAR 10-Q Q2 FY2026, published 2026-07-28)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | quarterly_operating_income | 1,345,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_2A39068943F3](/claim/clm_2A39068943F3.md) | [clm_1C0A2724D779](/claim/clm_1C0A2724D779.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.